| Structure |
Chemical Name |
CAS |
MF |
 |
2-ペンチン-1-オール |
6261-22-9 |
C5H8O |
 |
(Z)-フルボキサミン |
89035-92-7 |
C15H21F3N2O2 |
![(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione](/CAS/20180703/GIF/CB93954895.gif) |
(3aR,4S,7R,7aS)-2-(((1S,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione |
1448443-35-3 |
C28H36N4O2S |
 |
Pitavastatin Impurity 10 |
|
|
 |
Erlotinib Impurity 48 |
2304005-44-3 |
C8H8BrN |
 |
1,3-ジヒドロキシ-2-(ヒドロキシメチル)アントラキノン |
478-08-0 |
C15H10O5 |
 |
Posaconazole Succinyl Ester |
1488301-79-6 |
C41H46F2N8O7 |
 |
Rufinamide 2,6-Didesfluoro Impurity |
80819-65-4 |
C10H10N4O |
 |
Iohexol EP Impurity F |
1215856-35-1 |
C14H19I2N3O6 |
 |
2,5-ジヒドロキシ-3-メチル-6-(14-ノナデセニル)-2,5-シクロヘキサジエン-1,4-ジオン |
19833-20-6 |
C26H42O4 |
![2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]-](/CAS/20200611/GIF/2137823-20-0.gif) |
2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]- |
2137823-20-0 |
C41H47N5O2S2 |
 |
((2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl acetate |
2452301-09-4 |
C25H29ClO8 |
 |
1,6-ジメチル-10-メトキシエルゴリン-8β-メタノール |
35155-28-3 |
C18H24N2O2 |
![(6R)-7α-[[2-フラニル(メトキシイミノ)アセチル]アミノ]-3-ヒドロキシメチル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸](/CAS/GIF/56271-94-4.gif) |
(6R)-7α-[[2-フラニル(メトキシイミノ)アセチル]アミノ]-3-ヒドロキシメチル-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸 |
56271-94-4 |
C15H15N3O7S |
 |
7-ヒドロキシクロモン |
59887-89-7 |
C9H6O3 |
 |
4,7-Dimethoxyquinoline-6-carboxamide |
2839104-94-6 |
C12H12N2O3 |